The presence of immune tolerogenic environment in the context of EBV + DLBCL was also described by gene expression analysis, which revealed increased expression of PDL1, PDL2, LAG3, and TIM3 immune checkpoints and a higher protumoral CD163/CD68 “M2” macrophage polarization pattern [96]. This evidence concerns the gene CD163 and diffuse large B-cell lymphoma.